Enanta Pharmaceuticals Inc. (ENTA)
NASDAQ · Healthcare
Enanta Pharmaceuticals Inc. Income Statement 2020–2025
| Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 65.3M | 67.6M | 79.2M | 86.2M | 97.1M | 122.5M |
| Gross Profit | — | — | — | — | — | — |
| Profitability | ||||||
| Operating Income | -85.3M | -121.7M | -137.2M | -123.8M | -109.6M | -41.6M |
| EBITDA | -71.3M | -104.6M | -123.5M | -119.3M | -104.2M | -38.1M |
| Net Income | -81.9M | -116.0M | -133.8M | -121.8M | -79.0M | -36.2M |
| Per Share Data | ||||||
| EPS (diluted) | $-3.84 | $-5.48 | $-6.38 | $-5.91 | $-3.92 | $-1.81 |
| Shares Outstanding (dil.) | 21M | 21M | 21M | 21M | 20M | 20M |
Enanta Pharmaceuticals Inc. Income Statement — FAQ
Enanta Pharmaceuticals Inc. (ENTA) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ENTA's income statement history?
The chart and table above show Enanta Pharmaceuticals Inc.'s income statement by year and by quarter, including the growth rate.